Target intelligence / Profile preview

Plasmodium falciparum chloroquine resistance transporter (PfCRT)

Target
PfCRT
Molecular classification
Transporter
01

Overview

The Plasmodium falciparum chloroquine resistance transporter (PfCRT) is a 10-transmembrane domain protein located in the membrane of the parasite's acidic digestive vacuole. Under physiological conditions, wild-type PfCRT functions as a nutrient transporter, exporting host hemoglobin-derived oligopeptides and amino acids into the parasite cytosol to maintain osmotic homeostasis and support growth. However, specific point mutations in PfCRT, most notably the K76T substitution, confer resistance to the antimalarial drug chloroquine and related quinoline compounds. These mutations alter the transporter's substrate specificity, enabling it to actively efflux protonated antimalarial drugs out of the digestive vacuole, thereby preventing them from inhibiting heme detoxification. Consequently, PfCRT is a critical mediator of drug resistance in malaria and serves as a key target for developing resistance-reversing agents and novel antimalarial therapies.

Other names
Chloroquine resistance transporterCRTPfCRTPlasmodium falciparum chloroquine resistance transporter proteinCRT_PLAFA
02

Mechanism of action

Mutant PfCRT acts as a drug efflux pump that transports protonated chloroquine and other quinoline-like antimalarials out of the acidic digestive vacuole of the parasite, reducing drug accumulation at its site of action. In contrast, wild-type PfCRT functions as a nutrient transporter that exports host hemoglobin-derived oligopeptides and amino acids to maintain osmotic homeostasis and support parasite growth.

03

Biological functions

Nutrient transportOsmotic homeostasisDrug transportOther
04

Disease associations

Infection
05

Safety considerations

Development of multidrug resistanceAltered parasite fitnessCross-resistance to other quinoline antimalarialsReversal of resistance leading to collateral sensitivity to other drugs
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

pfcrt K76T mutationpfcrt C72S mutationpfcrt gene polymorphisms

Beyond the preview

Go deeper on Plasmodium falciparum chloroquine resistance transporter (PfCRT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum chloroquine resistance transporter (PfCRT).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call